← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #711 OF 1,000 MOST-CITED

Contamination with microorganisms, chemicals, filth, etc.

FDA cited this observation 23 times across 23 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods23
BY FISCAL YEAR
FY20201
FY20194
FY20189
FY20179

How FDA worded it — real examples

Proper precautions to protect food and food-packaging materials from contamination with microorganisms cannot be taken because of deficiencies in plant design.

Olam Processing Cote d'Ivoire S.A. · Abidjan · Foods · 2019-12-03

Proper precautions to protect food from contamination with microorganisms, filth and extraneous material cannot be taken because of deficiencies in plant construction and design.

Viti Foods · Suva · Foods · 2019-08-27

Proper precautions to protect food-contact surfaces from contamination with microorganisms and extraneous material cannot be taken because of deficiencies in plant.

Custom Ag-Pak, LLC · Hollister, California · Foods · 2019-07-02

Proper precautions to protect from contamination with extraneous material cannot be taken because of deficiencies in plant construction.

Yamaki Co., Ltd. · Iyo · Foods · 2019-02-01

Proper precautions to protect food and food-contact surfaces from contamination with filth and extraneous material cannot be taken because of deficiencies in plant construction and design.

KATSUOBUSHI NO KANEI CO.,LTD. · Kobe · Foods · 2019-01-22

Proper precautions to protect food and food-contact surfaces from contamination with cannot be taken because of deficiencies in plant.

Anahuac, Inc. · Mount Airy, North Carolina · Foods · 2018-08-23

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination controlFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →